LexDanaLexDanabeta
Inventor

Daekwon KIM

Inventor
KR

Overview

2→
Patents
2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
PatentTitleYear
12,479,847Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2202512,240,844Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025Patents assigned to VORONOI INC (2)· patent assignee history
2025Patents assigned to DANA FARBER CANCER INST INC (1)· patent assignee history
2025Based in KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VORONOI INC22025
DANA FARBER CANCER INST INC12025
Locations
LocationPatentsSpan
KR22025